$RGNX
REGENXBIO Inc.
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$8.10
▼-1.40%-$0.115
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateREGENXBIO Inc.
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is RGNX down today? It is at $8.10 (-1.40%), and our scanner flagged it 115 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment RGNX spikes, and full due diligence on RGNX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $RGNX 115 times in the last 30 days. Create a free account to track $RGNX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on RGNX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RGNX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Chan Mitchell Officer | Sold (automatic/other) | -5K | sold 3.8% | 123K | $46K at $9.32 | Sep 1, 26 |
Malzahn Craig Officer | Sold (automatic/other) | -234 | sold 0.3% | 82K | $2K at $9.32 | Sep 1, 26 |
Ciongoli Gregory Austin Director | Bought (open market) | +53K 0.08% of company | added 83% | 118K | $500K at $9.36 | Aug 27, 26 |
Ciongoli Gregory Austin Director | Bought (open market) | +49K 0.07% of company | added 100% | 65K | $450K at $9.14 | Aug 26, 26 |
Ciongoli Gregory Austin Director | Acquired (grant/award) | +15K 0.02% of company | n/a | 15K | n/a | Aug 25, 26 |
Christmas Patrick J. Officer | Sold (automatic/other) | -5K | sold 2.2% | 206K | $46K at $9.69 | Aug 1, 26 |
Pakola Steve Officer | Sold (automatic/other) | -7K 0.01% of company | sold 3.5% | 206K | $72K at $9.69 | Aug 1, 26 |
Pakola Steve Officer | Sold (automatic/other) | -2K | sold 1.0% | 213K | $29K at $13.64 | Jul 2, 26 |
Pakola Steve Officer | Other | 2K | added 1.0% | 215K | $17K at $7.86 | Jul 2, 26 |
Pakola Steve Officer | Sold (automatic/other) | -37K 0.06% of company | sold 15% | 213K | $472K at $12.86 | Jul 1, 26 |
Pakola Steve Officer | Other | 37K 0.06% of company | added 17% | 250K | $289K at $7.86 | Jul 1, 26 |
Simpson Curran Officer | Sold (automatic/other) | -7K 0.01% of company | sold 2.0% | 338K | $89K at $13.09 | Jul 1, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on RGNX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RGNX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
RGNX last traded at $8.10, down 1.40% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
REGENXBIO Inc. (RGNX) is next expected to report earnings on Thursday, November 5, 2026, about 46 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The RGNX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged RGNX 115 times in the last 30 days.
RGNX (REGENXBIO Inc.) trades on XNAS, with a market cap of about $530M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge RGNX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$RGNX discussion
Sign in to ask a question or join the discussion.